Episodes
Saturday Nov 20, 2021
Mythbusting LCS in Nursing: Smoking Cessation and Stigma (Part 1)
Saturday Nov 20, 2021
Saturday Nov 20, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, chats with nurse navigator Linda Dowling, RN, about smoking cessation and stigma in the lung cancer screening setting in part one of a four-part series.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Linda Dowling was a nurse navigator at Rush University Medical Center. After obtaining her BSN, Linda focused her career on outpatient oncology and thoracic nurse navigation, including implementing and growing Rush’s lung screening program and helping form the Tobacco Oversight Committee. Since this interview was recorded, she has retired from nursing.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS with Patients: Risks Related to Lung Cancer (Part 4)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
In the final part of their discussion, Dr. Debra Dyer, MD, and patient advocate Ron Simmons talk about the risks related to lung cancer.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Ron Simmons is a cancer survivor and experienced patient advocate. Ron was initially diagnosed with Stage 1 colon cancer through routine colonoscopy in 2013; his diagnosis with Stage 3 lung cancer four years later was decidedly less smooth. As of 2021, Ron still reports that he has no evidence of disease, and additionally was able to remove his chemotherapy port.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS with Patients: Lung Cancer Diagnosis (Part 3)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, and patient advocate Ron Simmons discuss the patient perspective of being diagnosed with lung cancer in part three of their conversation.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Ron Simmons is a cancer survivor and experienced patient advocate. Ron was initially diagnosed with Stage 1 colon cancer through routine colonoscopy in 2013; his diagnosis with Stage 3 lung cancer four years later was decidedly less smooth. As of 2021, Ron still reports that he has no evidence of disease, and additionally was able to remove his chemotherapy port.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, and patient advocate Ron Simmons continue their conversation with a discussion on the demographics of patients who are screened for lung cancer.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Ron Simmons is a cancer survivor and experienced patient advocate. Ron was initially diagnosed with Stage 1 colon cancer through routine colonoscopy in 2013; his diagnosis with Stage 3 lung cancer four years later was decidedly less smooth. As of 2021, Ron still reports that he has no evidence of disease, and additionally was able to remove his chemotherapy port.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS with Patients: Ron Simmons‘ Story (Part 1)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, starts her four-part conversation with Ron Simmons, a cancer survivor and patient advocate, by asking him to share his patient story.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Ron Simmons is a cancer survivor and experienced patient advocate. Ron was initially diagnosed with Stage 1 colon cancer through routine colonoscopy in 2013; his diagnosis with Stage 3 lung cancer four years later was decidedly less smooth. As of 2021, Ron still reports that he has no evidence of disease, and additionally was able to remove his chemotherapy port.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS in Radiology: The National Lung Cancer Roundtable (Part 5)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and recorded in 2020.
In the last part of their five-part conversation, Dr. Debra Dyer, MD, and Dr. Ella Kazerooni, MD, discuss Dr. Kazerooni’s work with the National Lung Cancer Roundtable.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Ella Kazerooni is a Professor of Radiology & Internal Medicine and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group. She is the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS in Radiology: Abnormal Lung Screening Results (Part 4)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
In part four of five of an ongoing conversation, Dr. Debra Dyer, MD, and Dr. Ella Kazerooni, MD, discuss from a radiology perspective what a patient should expect if their lung cancer screening CT exam is abnormal.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Ella Kazerooni is a Professor of Radiology & Internal Medicine and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group. She is the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS in Radiology: Radiation Dose (Part 3)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
Dr. Debra Dyer, MD, and Dr. Ella Kazerooni, MD, discuss concerns about radiation dose from a lung cancer screening CT in part three of their five-part conversation.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Ella Kazerooni is a Professor of Radiology & Internal Medicine and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group. She is the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS in Radiology: Patient Expectations (Part 2)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
In the second part of their five-part discussion, Dr. Debra Dyer, MD, continues her conversation with Dr. Ella Kazerooni, MD, about what patients should expect when they come in for a lung cancer screening CT exam.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Ella Kazerooni is a Professor of Radiology & Internal Medicine and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group. She is the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.
Additional information on this topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Friday Nov 19, 2021
Mythbusting LCS in Radiology: Role of the Radiologist (Part 1)
Friday Nov 19, 2021
Friday Nov 19, 2021
*This episode was originally part of the ACR Bulletin podcast and was recorded in 2020.
In this new five-part conversation, Dr. Debra Dyer, MD, speaks with Dr. Ella Kazerooni, MD, about the radiologist’s role in lung cancer screening.
As part of National Lung Cancer Awareness Month 2020, Dr. Debra Dyer, Chair of the ACR’s Lung Cancer Screening Steering Committee, had a series of conversations with stakeholders across the healthcare spectrum about myths in lung screening in the limited series “Mythbusting Lung Cancer Screening.”
Dr. Ella Kazerooni is a Professor of Radiology & Internal Medicine and serves as the Associate Chief Clinical Officer for the Diagnostic and Clinical Information Oversight Team within the University of Michigan Medical Group. She is the inaugural chair of the American Cancer Society’s National Lung Cancer Roundtable.
Additional information on this episode’s guest and topic, as well as the resources mentioned during the episode, can be found at https://www.acr.org/Clinical-Resources/Lung-Cancer-Screening-Resources.
Conversations in Lung Cancer
The American Cancer Society's National Lung Cancer Roundtable and the American College of Radiology's Lung Cancer Screening Steering Committee have partnered to create a podcast featuring candid and casual conversations about the work being done in lung cancer and health equity with the people doing that work.
The first season, “Mythbusting Lung Cancer Screening,” launched in 2020 and focused on combatting common myths found in treatment and discussion of lung cancer. The latest season, “The Power of Partnerships,” highlighted collaborations between patients, primary care, pulmonology, radiology, and health equity experts by sharing new data and existing programs aimed at increasing lung cancer screening rates in people who are medically underserved.
The new limited series, "LCS 201: Expanding Horizons," will focus how those already in the lung cancer space can take their programs to new heights, and will feature conversations on outreach, creating new screening opportunities, and more. Coming November 2023.